556099877	556099877	CD	B-NP	O
|	|	NNP	I-NP	O
SEHC	SEHC	NNP	I-NP	O
|	|	VBD	B-VP	O
85251678	85251678	CD	B-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
622894	622894	CD	B-NP	O
|	|	CC	I-NP	O
6/15/1998	6/15/1998	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	B-protein
DEHYDRATION	DEHYDRATION	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
Signed	Signed	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
DIS	DIS	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
2/10/1998	2/10/1998	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Signed	Signed	NNP	B-NP	O
Discharge	Discharge	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
10/21/1998	10/21/1998	CD	B-NP	O
FINAL	FINAL	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
:	:	:	O	O
-LRB-	-LRB-	NN	B-NP	B-protein
1	1	CD	I-NP	I-protein
-RRB-	-RRB-	NN	I-NP	I-protein
CORONARY	CORONARY	NN	I-NP	I-protein
ARTERY	ARTERY	NN	I-NP	I-protein
DISEASE	DISEASE	NN	I-NP	I-protein
-LRB-	-LRB-	SYM	B-NP	I-protein
2	2	CD	I-NP	I-protein
-RRB-	-RRB-	SYM	I-NP	I-protein
HYPERTENSION	HYPERTENSION	NN	I-NP	I-protein
-LRB-	-LRB-	NN	I-NP	I-protein
3	3	CD	I-NP	I-protein
-RRB-	-RRB-	NNP	I-NP	I-protein
OBESITY	OBESITY	NNP	I-NP	I-protein
-LRB-	-LRB-	NNP	I-NP	I-protein
4	4	CD	I-NP	I-protein
-RRB-	-RRB-	NNP	I-NP	I-protein
DIABETES	DIABETES	NNP	I-NP	O
,	,	,	O	O
INSULIN	INSULIN	NNP	B-NP	B-protein
REQUIRING	REQUIRING	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
5	5	CD	I-NP	O
-RRB-	-RRB-	HYPH	I-NP	O
DEPRESSION	DEPRESSION	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
6	6	CD	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
GOUT	GOUT	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
7	7	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
CHRONIC	CHRONIC	NNP	I-NP	O
HEARING	HEARING	NNP	I-NP	O
LOSS	LOSS	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
8	8	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
HISTORY	HISTORY	NNP	I-NP	O
OF	OF	IN	B-PP	O
CHOLECYSTECTOMY	CHOLECYSTECTOMY	NNP	B-NP	O
AND	AND	CC	O	O
APPENDECTOMY	APPENDECTOMY	NNP	B-NP	O
HISTORY	HISTORY	NNP	I-NP	O
OF	OF	IN	B-PP	O
PRESENT	PRESENT	NNP	B-NP	O
ILLNESS	ILLNESS	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
65	65	CD	I-NP	O
year	year	NN	I-NP	O
old	old	JJ	I-NP	O
woman	woman	NN	I-NP	O
with	with	IN	B-PP	O
insulin	insulin	NN	B-NP	B-protein
requiring	require	VBG	B-VP	O
diabetes	diabetes	NN	B-NP	O
mellitus	mellitus	NN	I-NP	O
,	,	,	O	O
hypertension	hypertension	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
known	know	VBN	B-VP	O
coronary	coronary	JJ	B-NP	O
artery	artery	NN	I-NP	O
disease	disease	NN	I-NP	O
who	who	WP	B-NP	O
presented	present	VBD	B-VP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
day	day	NN	I-NP	O
of	of	IN	B-PP	O
admission	admission	NN	B-NP	O
after	after	IN	B-PP	O
having	have	VBG	B-VP	O
a	a	DT	B-NP	O
fall	fall	NN	I-NP	O
at	at	IN	B-PP	O
home	home	NN	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
noted	note	VBN	I-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
emergency	emergency	NN	I-NP	O
room	room	NN	I-NP	O
to	to	TO	B-VP	O
have	have	VB	I-VP	O
new	new	JJ	B-NP	O
ECG	ECG	NN	I-NP	O
changes	change	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
recently	recently	RB	I-VP	O
catheterized	catheterize	VBN	I-VP	O
in	in	IN	B-PP	O
October	October	NNP	B-NP	O
of	of	IN	B-PP	O
1998	1998	CD	B-NP	O
at	at	IN	B-PP	O
which	which	WDT	B-NP	O
time	time	NN	I-NP	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
found	find	VBN	I-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
a	a	DT	B-NP	O
100	100	CD	I-NP	O
%	%	NN	I-NP	O
left	leave	VBD	B-VP	O
anterior	anterior	RB	I-VP	O
descending	descend	VBG	I-VP	O
artery	artery	NN	B-NP	O
lesion	lesion	NN	I-NP	O
,	,	,	O	O
a	a	DT	B-NP	O
100	100	CD	I-NP	O
%	%	NN	I-NP	O
right	right	JJ	I-NP	O
coronary	coronary	JJ	I-NP	O
artery	artery	NN	I-NP	O
lesion	lesion	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
a	a	DT	B-NP	O
40	40	CD	I-NP	O
%	%	NN	I-NP	O
obtuse	obtuse	NN	I-NP	O
marginal	marginal	JJ	I-NP	O
1	1	CD	I-NP	O
lesion	lesion	NN	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
left	left	JJ	I-NP	O
anterior	anterior	JJ	I-NP	O
descending	descend	VBG	I-NP	O
artery	artery	NN	I-NP	O
and	and	CC	I-NP	O
right	right	JJ	I-NP	O
coronary	coronary	JJ	I-NP	O
artery	artery	NN	I-NP	O
territories	territory	NNS	I-NP	O
were	be	VBD	B-VP	O
being	be	VBG	I-VP	O
served	serve	VBN	I-VP	O
by	by	IN	B-PP	O
collaterals	collateral	NNS	B-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
decision	decision	NN	I-NP	O
was	be	VBD	B-VP	O
made	make	VBN	I-VP	O
to	to	TO	B-VP	O
manage	manage	VB	I-VP	O
her	her	PRP	B-NP	O
medically	medically	RB	B-ADVP	O
on	on	IN	B-PP	O
enteric	enteric	JJ	B-NP	O
coated	coated	JJ	I-NP	O
aspirin	aspirin	NN	I-NP	O
,	,	,	O	O
Atenolol	Atenolol	NN	B-NP	O
50	50	CD	I-NP	O
mg	mg	NN	I-NP	O
q.d.	q.d.	NN	I-NP	O
,	,	,	O	O
Lisinopril	Lisinopril	NNP	B-NP	O
30	30	CD	I-NP	O
mg	mg	NN	I-NP	O
q.d.	q.d.	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
Pravacid	Pravacid	NN	B-NP	O
at	at	IN	B-PP	O
20	20	CD	B-NP	O
mg	mg	NN	I-NP	O
q.d.	q.d.	NN	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
Bumex	Bumex	NNP	I-NP	O
dose	dose	NN	I-NP	O
was	be	VBD	B-VP	O
recently	recently	RB	I-VP	O
increased	increase	VBN	I-VP	O
from	from	IN	B-PP	O
1	1	CD	B-NP	O
to	to	TO	I-NP	O
2	2	CD	I-NP	O
q.d.	q.d.	NN	I-NP	O
on	on	IN	B-PP	O
1/12/98	1/12/98	CD	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
recently	recently	RB	I-VP	O
admitted	admit	VBN	I-VP	O
from	from	IN	B-PP	O
11/7/98	11/7/98	CD	B-NP	O
to	to	TO	B-PP	O
8/10/98	8/10/98	CD	B-NP	O
for	for	IN	B-PP	O
increasing	increase	VBG	B-NP	O
shortness	shortness	NN	I-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
and	and	CC	O	O
some	some	DT	B-NP	O
chest	chest	NN	I-NP	O
pain	pain	NN	I-NP	O
and	and	CC	O	O
had	have	VBD	B-VP	O
catheterization	catheterization	NN	B-NP	O
with	with	IN	B-PP	O
results	result	NNS	B-NP	O
as	as	IN	B-SBAR	O
described	describe	VBN	B-VP	O
above	above	RB	B-ADVP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
discharged	discharge	VBN	I-VP	O
to	to	TO	B-PP	O
home	home	NN	B-NP	O
on	on	IN	B-PP	O
an	an	DT	B-NP	O
increase	increase	NN	I-NP	O
in	in	IN	B-PP	O
her	her	PRP$	B-NP	O
medical	medical	JJ	I-NP	O
regimen	regimen	NN	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
last	last	JJ	I-NP	O
echocardiogram	echocardiogram	NN	I-NP	O
was	be	VBD	B-VP	O
done	do	VBN	I-VP	O
in	in	IN	B-PP	O
February	February	NNP	B-NP	O
of	of	IN	B-PP	O
1997	1997	CD	B-NP	O
and	and	CC	O	O
this	this	DT	B-NP	O
showed	show	VBD	B-VP	O
a	a	DT	B-NP	O
moderately	moderately	RB	I-NP	O
dilated	dilated	JJ	I-NP	O
left	left	JJ	I-NP	O
ventricle	ventricle	NN	I-NP	O
with	with	IN	B-PP	O
septal	septal	JJ	B-NP	O
akinesis	akinesis	NN	I-NP	O
,	,	,	O	O
inferior	inferior	JJ	B-NP	O
hypokinesis	hypokinesis	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
an	an	DT	B-NP	O
ejection	ejection	NN	I-NP	O
fraction	fraction	NN	I-NP	O
of	of	IN	B-PP	O
35	35	CD	B-NP	O
%	%	NN	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
right	right	JJ	I-NP	O
ventricular	ventricular	JJ	I-NP	O
size	size	NN	I-NP	O
and	and	CC	I-NP	O
function	function	NN	I-NP	O
were	be	VBD	B-VP	O
normal	normal	JJ	B-ADJP	O
.	.	.	O	O

There	There	EX	B-NP	O
was	be	VBD	B-VP	O
mild	mild	JJ	B-NP	O
left	left	JJ	I-NP	O
atrial	atrial	JJ	I-NP	O
enlargement	enlargement	NN	I-NP	O
,	,	,	O	O
mild	mild	JJ	B-NP	O
mitral	mitral	JJ	I-NP	O
regurgitation	regurgitation	NN	I-NP	O
,	,	,	O	O
mild	mild	JJ	B-NP	O
tricuspid	tricuspid	JJ	I-NP	O
regurgitation	regurgitation	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
trivial	trivial	JJ	B-NP	O
aortic	aortic	JJ	I-NP	O
insufficiency	insufficiency	NN	I-NP	O
.	.	.	O	O

Since	Since	IN	B-SBAR	O
discharge	discharge	NN	B-NP	O
she	she	PRP	B-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
followed	follow	VBN	I-VP	O
in	in	IN	B-PP	O
Tauershingdeneers	Tauershingdeneers	NNP	B-NP	O
Hospital	Hospital	NNP	I-NP	O
by	by	IN	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Goodfield	Goodfield	NNP	I-NP	O
,	,	,	O	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
by	by	IN	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Adamyan	Adamyan	NNP	I-NP	O
of	of	IN	B-PP	O
cardiology	cardiology	NN	B-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
Bumex	Bumex	NNP	I-NP	O
dose	dose	NN	I-NP	O
as	as	IN	B-SBAR	O
described	describe	VBN	B-VP	O
above	above	IN	B-PP	O
was	be	VBD	B-VP	O
increased	increase	VBN	I-VP	O
on	on	IN	B-PP	O
1/12/98	1/12/98	CD	B-NP	O
because	because	IN	B-PP	O
of	of	IN	I-PP	O
fluid	fluid	NN	B-NP	O
overload	overload	NN	I-NP	O
.	.	.	O	O

Of	Of	IN	B-PP	O
note	note	NN	B-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
has	have	VBZ	B-VP	O
had	have	VBN	I-VP	O
very	very	RB	B-NP	O
poor	poor	JJ	I-NP	O
glycemic	glycemic	JJ	I-NP	O
control	control	NN	I-NP	O
over	over	IN	B-PP	O
the	the	DT	B-NP	O
two	two	CD	I-NP	O
months	month	NNS	I-NP	O
prior	prior	RB	B-ADVP	O
to	to	TO	B-PP	O
admission	admission	NN	B-NP	O
with	with	IN	B-PP	O
blood	blood	NN	B-NP	O
sugars	sugar	NNS	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
300	300	CD	I-NP	O
to	to	TO	I-NP	O
400	400	CD	I-NP	O
range	range	NN	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
last	last	JJ	I-NP	O
A1C	A1C	NN	I-NP	B-protein
was	be	VBD	B-VP	O
12.3	12.3	CD	B-NP	O
on	on	IN	B-PP	O
1/12/98	1/12/98	CD	B-NP	O
.	.	.	O	O

It	It	PRP	B-NP	O
had	have	VBD	B-VP	O
been	be	VBN	I-VP	O
6.0	6.0	CD	B-NP	O
on	on	IN	B-PP	O
9/20/97	9/20/97	CD	B-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
the	the	DT	B-NP	O
day	day	NN	I-NP	O
of	of	IN	B-PP	O
admission	admission	NN	B-NP	O
after	after	IN	B-PP	O
standing	stand	VBG	B-VP	O
up	up	RP	B-PRT	O
to	to	TO	B-VP	O
get	get	VB	I-VP	O
her	her	PRP$	B-NP	O
insulin	insulin	NN	I-NP	B-protein
,	,	,	O	O
she	she	PRP	B-NP	O
felt	feel	VBD	B-VP	O
lightheaded	lightheade	VBN	B-ADJP	O
and	and	CC	O	O
fell	fall	VBD	B-VP	O
backwards	backward	NNS	B-NP	O
,	,	,	O	O
landing	land	VBG	B-VP	O
on	on	IN	B-PP	O
her	her	PRP$	B-NP	O
coccyx	coccyx	NN	I-NP	O
into	into	IN	B-PP	O
a	a	DT	B-NP	O
chair	chair	NN	I-NP	O
but	but	CC	O	O
the	the	DT	B-NP	O
chair	chair	NN	I-NP	O
fell	fall	VBD	B-VP	O
backwards	backwards	RB	B-ADVP	O
and	and	CC	O	O
so	so	RB	B-ADVP	O
she	she	PRP	B-NP	O
fell	fall	VBD	B-VP	O
backwards	backwards	RB	B-ADVP	O
as	as	RB	B-ADVP	O
well	well	RB	I-ADVP	O
.	.	.	O	O

She	She	PRP	B-NP	O
reported	report	VBD	B-VP	O
that	that	IN	B-SBAR	O
for	for	IN	B-PP	O
two	two	CD	B-NP	O
or	or	CC	I-NP	O
three	three	CD	I-NP	O
days	day	NNS	I-NP	O
prior	prior	RB	B-ADVP	O
to	to	TO	B-PP	O
admission	admission	NN	B-NP	O
she	she	PRP	B-NP	O
had	have	VBD	B-VP	O
been	be	VBN	I-VP	O
having	have	VBG	I-VP	O
some	some	DT	B-NP	O
lightheadedness	lightheadedness	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
denied	deny	VBD	B-VP	O
any	any	DT	B-NP	O
visual	visual	JJ	I-NP	O
changes	change	NNS	I-NP	O
or	or	CC	I-NP	O
weakness	weakness	NN	I-NP	O
,	,	,	O	O
loss	loss	NN	B-NP	O
of	of	IN	B-PP	O
consciousness	consciousness	NN	B-NP	O
or	or	CC	O	O
head	head	NN	B-NP	O
injury	injury	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
denied	deny	VBD	B-VP	O
any	any	DT	B-NP	O
seizure	seizure	NN	I-NP	O
or	or	CC	I-NP	O
seizure	seizure	NN	I-NP	O
history	history	NN	I-NP	O
or	or	CC	I-NP	O
loss	loss	NN	I-NP	O
of	of	IN	B-PP	O
urine	urine	NN	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
unable	unable	JJ	B-ADJP	O
to	to	TO	B-VP	O
get	get	VB	I-VP	O
up	up	RP	B-PRT	O
and	and	CC	O	O
called	call	VBD	B-VP	O
for	for	IN	B-PP	O
help	help	NN	B-NP	O
and	and	CC	O	O
an	an	DT	B-NP	O
ambulance	ambulance	NN	I-NP	O
brought	bring	VBD	B-VP	O
her	her	PRP	B-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
emergency	emergency	NN	I-NP	O
room	room	NN	I-NP	O
department	department	NN	I-NP	O
.	.	.	O	O

REVIEW	REVIEW	NNP	B-NP	O
OF	OF	IN	B-PP	O
SYSTEMS	SYSTEMS	NNP	B-NP	O
:	:	:	O	O
She	She	NNP	B-NP	O
reported	report	VBD	B-VP	O
occasional	occasional	JJ	B-NP	O
diarrhea	diarrhea	NN	I-NP	O
and	and	CC	I-NP	O
constipation	constipation	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
had	have	VBD	B-VP	O
no	no	DT	B-NP	O
fever	fever	NN	I-NP	O
or	or	CC	I-NP	O
chills	chill	NNS	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
cough	cough	NN	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
urinary	urinary	JJ	I-NP	O
symptoms	symptom	NNS	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
also	also	RB	B-ADVP	O
denied	deny	VBD	B-VP	O
any	any	DT	B-NP	O
dietary	dietary	JJ	I-NP	O
indiscretion	indiscretion	NN	I-NP	O
or	or	CC	I-NP	O
non-compliance	non-compliance	NN	I-NP	O
with	with	IN	B-PP	O
her	her	PRP$	B-NP	O
insulin	insulin	NN	I-NP	B-protein
.	.	.	O	O

She	She	PRP	B-NP	O
reports	report	VBZ	B-VP	O
that	that	IN	B-SBAR	O
she	she	PRP	B-NP	O
has	have	VBZ	B-VP	O
chest	chest	NN	B-NP	O
pain	pain	NN	I-NP	O
approximately	approximately	RB	B-NP	O
two	two	CD	I-NP	O
times	time	NNS	I-NP	O
per	per	IN	B-PP	O
week	week	NN	B-NP	O
but	but	CC	O	O
denied	deny	VBD	B-VP	O
having	have	VBG	I-VP	O
any	any	DT	B-NP	O
chest	ch	JJS	I-NP	O
pain	pain	NN	I-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
day	day	NN	I-NP	O
of	of	IN	B-PP	O
admission	admission	NN	B-NP	O
.	.	.	O	O

MEDICATIONS	MEDICATIONS	NNS	B-NP	O
:	:	:	O	O
Enteric	Enteric	JJ	B-NP	O
coated	coated	JJ	I-NP	O
aspirin	aspirin	NN	I-NP	O
325	325	CD	I-NP	O
mg	mg	NN	I-NP	O
q.d.	q.d.	NN	I-NP	O
,	,	,	O	O
Atenolol	Atenolol	NN	B-NP	O
50	50	CD	I-NP	O
mg	mg	NN	I-NP	O
q.d.	q.d.	NN	I-NP	O
,	,	,	O	O
Isordil	Isordil	NN	B-NP	O
20	20	CD	I-NP	O
mg	mg	NN	I-NP	O
t.i.d.	t.i.d.	NN	I-NP	O
,	,	,	O	O
Lisinopril	Lisinopril	NNP	B-NP	O
30	30	CD	I-NP	O
mg	mg	NN	I-NP	O
q.d.	q.d.	NN	I-NP	O
,	,	,	O	O
Bumex	Bumex	NNP	B-NP	O
2	2	CD	I-NP	O
mg	mg	NN	I-NP	O
q.d.	q.d.	RB	B-ADVP	O
since	since	IN	B-PP	O
1/12/98	1/12/98	CD	B-NP	O
,	,	,	O	O
Pravastatin	Pravastatin	NN	B-NP	O
20	20	CD	I-NP	O
mg	mg	NN	I-NP	O
q.d.	q.d.	NN	I-NP	O
,	,	,	O	O
Omeprazole	Omeprazole	NN	B-NP	O
20	20	CD	I-NP	O
mg	mg	NN	I-NP	O
q.d.	q.d.	NN	I-NP	O
,	,	,	O	O
insulin	insulin	NN	B-NP	O
NPH	NPH	NN	I-NP	O
75	75	CD	B-NP	O
q.a.m.	q.a.m.	NN	I-NP	O
and	and	CC	O	O
35	35	CD	B-NP	O
q.p.m.	q.p.m.	NN	I-NP	O
,	,	,	O	O
regular	regular	JJ	B-NP	O
25	25	CD	I-NP	O
q.a.m.	q.a.m.	NN	I-NP	O
and	and	CC	O	O
15	15	CD	B-NP	O
q.p.m.	q.p.m.	NN	I-NP	O
,	,	,	O	O
Trazadone	Trazadone	NN	B-NP	O
100	100	CD	I-NP	O
mg	mg	NN	I-NP	O
qhs	qh	NNS	I-NP	O
p.r.n.	p.r.n.	NN	I-NP	O
,	,	,	O	O
Allegra	Allegra	NNP	B-NP	O
60	60	CD	I-NP	O
mg	mg	NN	I-NP	O
b.i.d.	b.i.d.	RB	B-ADVP	O
,	,	,	O	O
Proventil	Proventil	IN	B-NP	O
2	2	CD	I-NP	O
b.i.d.	b.i.d.	NN	I-NP	O
PAST	PAST	NNP	I-NP	O
MEDICAL	MEDICAL	NNP	I-NP	O
HISTORY	HISTORY	NNP	I-NP	O
:	:	:	O	O
Coronary	Coronary	JJ	B-NP	O
artery	artery	NN	I-NP	O
disease	disease	NN	I-NP	O
as	as	IN	B-SBAR	O
noted	note	VBN	B-VP	O
above	above	RB	B-ADVP	O
.	.	.	O	O

Hypertension	Hypertension	NN	B-NP	O
.	.	.	O	O

Obesity	Obesity	NN	B-NP	O
.	.	.	O	O

Insulin-dependent	Insulin-dependent	JJ	B-NP	O
diabetes	diabetes	NN	I-NP	O
mellitus	mellitus	NN	I-NP	O
.	.	.	O	O

Depression	Depression	NN	B-NP	O
.	.	.	O	O

Gout	Gout	NNP	B-NP	O
.	.	.	O	O

Chronic	Chronic	JJ	B-NP	O
hearing	hearing	NN	I-NP	O
loss	loss	NN	I-NP	O
requiring	require	VBG	B-VP	O
hearing	hearing	NN	B-NP	O
aids	aid	NNS	I-NP	O
bilaterally	bilaterally	RB	B-ADVP	O
.	.	.	O	O

History	History	NN	B-NP	O
of	of	IN	B-PP	O
cholecystectomy	cholecystectomy	NN	B-NP	O
and	and	CC	I-NP	O
appendectomy	appendectomy	NN	I-NP	O
in	in	IN	B-PP	O
past	past	NN	B-NP	O
.	.	.	O	O

FAMILY	FAMILY	NN	B-NP	O
HISTORY	HISTORY	NN	I-NP	O
:	:	:	O	O
Unremarkable	Unremarkable	JJ	B-ADJP	O
.	.	.	O	O

SOCIAL	SOCIAL	JJ	B-NP	O
HISTORY	HISTORY	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
lives	live	VBZ	B-VP	O
alone	alone	RB	B-ADVP	O
and	and	CC	O	O
has	have	VBZ	B-VP	O
a	a	DT	B-NP	O
visiting	visit	VBG	I-NP	O
nurse	nurse	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
use	use	VBP	B-VP	O
to	to	TO	I-VP	O
work	work	VB	I-VP	O
in	in	IN	B-PP	O
housekeeping	housekeeping	NN	B-NP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
Mo	Mo	NNP	I-NP	O
Dessimed	Dessimed	NNP	I-NP	O
Memorial	Memorial	NNP	I-NP	O
Hospital	Hospital	NNP	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
has	have	VBZ	B-VP	O
a	a	DT	B-NP	O
remote	remote	JJ	I-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
smoking	smoking	NN	B-NP	O
but	but	CC	O	O
does	do	VBZ	B-VP	O
not	not	RB	I-VP	O
drink	drink	VB	I-VP	O
any	any	DT	B-NP	O
alcohol	alcohol	NN	I-NP	O
.	.	.	O	O

PHYSICAL	PHYSICAL	JJ	B-NP	O
EXAMINATION	EXAMINATION	NN	I-NP	O
:	:	:	O	O
She	She	PRP	B-NP	O
is	be	VBZ	B-VP	O
an	an	DT	B-NP	O
obese	obese	JJ	I-NP	O
woman	woman	NN	I-NP	O
in	in	IN	B-PP	O
no	no	DT	B-NP	O
acute	acute	JJ	I-NP	O
distress	distress	NN	I-NP	O
.	.	.	O	O

Temperature	Temperature	NN	B-NP	O
98.3	98.3	CD	B-NP	O
degrees	degree	NNS	I-NP	O
,	,	,	O	O
pulse	pulse	NN	B-NP	O
95	95	CD	I-NP	O
,	,	,	O	O
blood	blood	NN	B-NP	O
pressure	pressure	NN	I-NP	O
109/63	109/63	CD	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
room	room	NN	I-NP	O
air	air	NN	I-NP	O
saturation	saturation	NN	I-NP	O
was	be	VBD	B-VP	O
95	95	CD	B-NP	O
%	%	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
not	not	RB	O	O
orthostatic	orthostatic	JJ	B-ADJP	O
.	.	.	O	O

HEENT	HEENT	NN	B-NP	O
:	:	:	O	O
Unremarkable	Unremarkable	JJ	B-ADJP	O
.	.	.	O	O

Jugular	Jugular	JJ	B-NP	O
venous	venous	JJ	I-NP	O
distension	distension	NN	I-NP	O
difficult	difficult	JJ	B-ADJP	O
to	to	TO	B-VP	O
assess	assess	VB	I-VP	O
because	because	IN	B-PP	O
of	of	IN	I-PP	O
her	her	PRP$	B-NP	O
habitus	habitus	NN	I-NP	O
.	.	.	O	O

Heart	Heart	NN	B-NP	O
:	:	:	O	O
Regular	Regular	JJ	B-NP	O
rate	rate	NN	I-NP	O
and	and	CC	I-NP	O
rhythm	rhythm	NN	I-NP	O
.	.	.	O	O

S1	S1	NN	B-NP	B-protein
and	and	CC	I-NP	O
S2	S2	NN	I-NP	O
distant	distant	NN	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
murmurs	murmur	NNS	I-NP	O
,	,	,	O	O
rubs	rub	NNS	B-NP	O
,	,	,	O	O
or	or	CC	O	O
gallops	gallop	NNS	B-NP	O
.	.	.	O	O

Lungs	Lung	NNS	B-NP	O
clear	clear	JJ	B-ADJP	O
with	with	IN	B-PP	O
exception	exception	NN	B-NP	O
of	of	IN	B-PP	O
question	question	NN	B-NP	O
of	of	IN	B-PP	O
some	some	DT	B-NP	O
rales	rale	NNS	I-NP	O
at	at	IN	B-PP	O
bases	base	NNS	B-NP	O
.	.	.	O	O

This	This	DT	B-NP	O
was	be	VBD	B-VP	O
also	also	RB	B-ADVP	O
difficult	difficult	JJ	B-ADJP	O
to	to	TO	B-VP	O
assess	assess	VB	I-VP	O
due	due	IN	B-PP	O
to	to	TO	B-PP	O
poor	poor	JJ	B-NP	O
inspiratory	inspiratory	JJ	I-NP	O
effort	effort	NN	I-NP	O
.	.	.	O	O

Abdomen	Abdoman	NNS	B-NP	O
:	:	:	O	O
Benign	Benign	JJ	B-ADJP	O
.	.	.	O	O

Extremities	Extremity	NNS	B-NP	O
:	:	:	O	O
1	1	CD	B-NP	O
+	+	CC	O	O
edema	edema	NN	B-NP	O
at	at	IN	B-PP	O
feet	foot	NNS	B-NP	O
only	only	RB	B-ADVP	O
.	.	.	O	O

Neurologic	Neurologic	JJ	B-ADJP	O
:	:	:	O	O
Nonfocal	Nonfocal	JJ	B-ADJP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
an	an	DT	B-NP	O
appropriate	appropriate	JJ	I-NP	O
historian	historian	NN	I-NP	O
but	but	CC	O	O
had	have	VBD	B-VP	O
difficulty	difficulty	NN	B-NP	O
hearing	hear	VBG	B-VP	O
some	some	DT	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
questions	question	NNS	I-NP	O
.	.	.	O	O

LABORATORY	LABORATORY	NN	B-NP	O
DATA	DATA	NN	I-NP	O
:	:	:	O	O
Normal	Normal	JJ	B-NP	O
set	set	NN	I-NP	O
of	of	IN	B-PP	O
electrolytes	electrolyte	NNS	B-NP	O
with	with	IN	B-PP	O
BUN	BUN	NN	B-NP	B-DNA
58	58	CD	I-NP	I-DNA
,	,	,	O	O
creatinine	creatinine	NN	B-NP	O
2.4	2.4	CD	I-NP	O
.	.	.	O	O

Blood	Blood	NN	B-NP	O
sugar	sugar	NN	I-NP	O
435	435	CD	I-NP	O
.	.	.	O	O

Anion	Anion	NN	B-NP	O
gap	gap	NN	I-NP	O
16	16	CD	I-NP	O
.	.	.	O	O

Arterial	Arterial	JJ	B-NP	O
blood	blood	NN	I-NP	O
gas	gas	NN	I-NP	O
on	on	IN	B-PP	O
room	room	NN	B-NP	O
air	air	NN	I-NP	O
:	:	:	O	O
pH	pH	NN	B-NP	O
7.4	7.4	CD	I-NP	O
,	,	,	O	O
pCO2	pCO2	NN	B-NP	O
40	40	CD	I-NP	O
,	,	,	O	O
pO2	pO2	NN	B-NP	O
69	69	CD	I-NP	O
,	,	,	O	O
oxygen	oxygen	NN	B-NP	O
saturation	saturation	NN	I-NP	O
94	94	CD	B-NP	O
%	%	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
first	first	JJ	I-NP	O
CK	CK	NN	I-NP	O
done	do	VBN	B-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
emergency	emergency	NN	I-NP	O
room	room	NN	I-NP	O
department	department	NN	I-NP	O
was	be	VBD	B-VP	O
194	194	CD	B-NP	O
.	.	.	O	O

An	An	DT	B-NP	O
ACE	ACE	NN	I-NP	O
test	test	NN	I-NP	O
was	be	VBD	B-VP	O
positive	positive	JJ	B-ADJP	O
but	but	CC	O	O
beta	beta	NN	B-NP	O
hydroxybutyrate	hydroxybutyrate	NN	I-NP	O
was	be	VBD	B-VP	O
negative	negative	JJ	B-ADJP	O
with	with	IN	B-PP	O
triponin	triponin	NN	B-NP	O
of	of	IN	B-PP	O
0	0	CD	B-NP	O
.	.	.	O	O

WBC	WBC	NNP	B-NP	B-protein
7	7	CD	I-NP	I-protein
,	,	,	O	O
hematocrit	hematocrit	NN	B-NP	O
37	37	CD	I-NP	O
,	,	,	O	O
platelet	platelet	NN	B-NP	B-protein
count	count	NN	I-NP	I-protein
167	167	CD	I-NP	I-protein
.	.	.	O	O

Coagulase	Coagulase	NN	B-NP	B-protein
was	be	VBD	B-VP	O
within	within	IN	B-PP	O
normal	normal	JJ	B-NP	O
limits	limit	NNS	I-NP	O
.	.	.	O	O

Urinalysis	Urinalysis	NN	B-NP	O
was	be	VBD	B-VP	O
remarkable	remarkable	JJ	B-ADJP	O
for	for	IN	B-PP	O
3	3	CD	B-NP	O
+	+	SYM	I-NP	O
glucose	glucose	NN	I-NP	O
with	with	IN	B-PP	O
no	no	DT	B-NP	O
ketones	ketone	NNS	I-NP	O
,	,	,	O	O
1	1	CD	B-NP	O
+	+	SYM	I-NP	O
esterace	esterace	NN	I-NP	O
,	,	,	O	O
negative	negative	JJ	B-NP	O
nitrite	nitrite	NN	I-NP	O
,	,	,	O	O
20	20	CD	B-NP	O
to	to	TO	I-NP	O
25	25	CD	I-NP	O
white	white	JJ	I-NP	O
blood	blood	NN	I-NP	O
cells	cell	NNS	I-NP	O
,	,	,	O	O
2	2	CD	B-NP	O
to	to	TO	I-NP	O
3	3	CD	I-NP	O
red	red	JJ	I-NP	O
blood	blood	NN	I-NP	O
cells	cell	NNS	I-NP	O
,	,	,	O	O
2	2	CD	B-NP	O
+	+	SYM	I-NP	O
bacteria	bacteria	NNS	I-NP	O
,	,	,	O	O
and	and	CC	O	O
1	1	CD	B-NP	O
+	+	SYM	I-NP	O
yeast	yeast	NN	I-NP	O
.	.	.	O	O

Urine	Urine	NN	B-NP	B-cell_line
culture	culture	NN	I-NP	I-cell_line
was	be	VBD	B-VP	O
sent	send	VBN	I-VP	O
and	and	CC	O	O
came	come	VBD	B-VP	O
back	back	RB	B-ADVP	O
negative	negative	JJ	B-ADJP	O
.	.	.	O	O

ECG	ECG	NN	B-NP	B-protein
was	be	VBD	B-VP	O
normal	normal	JJ	B-NP	O
sinus	sinus	NN	I-NP	O
rhythm	rhythm	NN	I-NP	O
at	at	IN	B-PP	O
rate	rate	NN	B-NP	O
of	of	IN	B-PP	O
92	92	CD	B-NP	O
with	with	IN	B-PP	O
intervals	interval	NNS	B-NP	O
of	of	IN	B-PP	O
0.15	0.15	CD	B-NP	O
,	,	,	I-NP	O
0.1	0.1	CD	I-NP	O
,	,	,	O	O
and	and	CC	O	O
0.324	0.324	CD	B-NP	O
,	,	,	O	O
an	an	DT	B-NP	O
axis	axis	NN	I-NP	O
of	of	IN	B-PP	O
32	32	CD	B-NP	O
,	,	,	O	O
and	and	CC	O	O
left	leave	VBD	B-VP	O
atrial	atrial	JJ	B-NP	O
enlargement	enlargement	NN	I-NP	O
.	.	.	O	O

There	There	EX	B-NP	O
were	be	VBD	B-VP	O
new	new	JJ	B-NP	O
T-wave	T-wave	NN	I-NP	O
inversions	inversion	NNS	I-NP	O
in	in	IN	B-PP	O
leads	lead	NNS	B-NP	O
1	1	CD	B-NP	O
and	and	CC	O	O
L	L	NN	B-NP	O
with	with	IN	B-PP	O
biphasic	biphasic	JJ	B-NP	O
T-waves	T-wave	NNS	I-NP	O
in	in	IN	B-PP	O
V4	V4	NN	B-NP	O
through	through	IN	B-PP	O
V6	V6	NN	B-NP	B-protein
compared	compare	VBN	B-PP	O
with	with	IN	B-PP	O
her	her	PRP$	B-NP	O
ECG	ECG	NN	I-NP	O
of	of	IN	B-PP	O
4/13/97	4/13/97	CD	B-NP	O
.	.	.	O	O

ASSESSMENT	ASSESSMENT	NN	B-NP	O
:	:	:	O	O
In	In	IN	B-PP	O
short	short	JJ	B-ADJP	O
,	,	,	O	O
this	this	DT	B-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
65	65	CD	I-NP	O
year	year	NN	I-NP	O
old	old	JJ	I-NP	O
woman	woman	NN	I-NP	O
with	with	IN	B-PP	O
known	known	JJ	B-NP	O
two	two	CD	I-NP	O
vessel	vessel	NN	I-NP	O
coronary	coronary	JJ	I-NP	O
artery	artery	NN	I-NP	O
disease	disease	NN	I-NP	O
,	,	,	O	O
hypertension	hypertension	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
insulin-dependent	insulin-dependent	JJ	B-NP	O
diabetes	diabetes	NN	I-NP	O
mellitus	mellitus	NN	I-NP	O
under	under	IN	B-PP	O
poor	poor	JJ	B-NP	O
glycemic	glycemic	JJ	I-NP	O
control	control	NN	I-NP	O
recently	recently	RB	B-ADVP	O
,	,	,	O	O
now	now	RB	B-ADVP	O
presenting	present	VBG	B-VP	O
with	with	IN	B-PP	O
hyperglycemia	hyperglycemia	NN	B-NP	O
,	,	,	O	O
dehydration	dehydration	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
new	new	JJ	B-NP	O
ECG	ECG	NN	I-NP	O
changes	change	NNS	I-NP	O
suggestive	suggestive	JJ	B-ADJP	O
of	of	IN	B-PP	O
lateral	lateral	JJ	B-NP	O
ischemia	ischemia	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
admitted	admit	VBN	I-VP	O
for	for	IN	B-PP	O
rule	rule	NN	B-NP	O
out	out	IN	B-PP	O
of	of	IN	B-PP	O
myocardial	myocardial	JJ	B-NP	O
infarction	infarction	NN	I-NP	O
and	and	CC	I-NP	O
monitoring	monitoring	NN	I-NP	O
.	.	.	O	O

HOSPITAL	HOSPITAL	NNP	B-NP	O
COURSE	COURSE	NNP	I-NP	O
:	:	:	O	O
Cardiovascular	Cardiovascular	NNP	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
admitted	admit	VBN	I-VP	O
and	and	CC	O	O
placed	place	VBN	B-VP	O
on	on	IN	B-PP	O
a	a	DT	B-NP	O
cardiac	cardiac	JJ	I-NP	O
monitor	monitor	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
ruled	rule	VBD	B-VP	O
out	out	RP	B-PRT	O
for	for	IN	B-PP	O
myocardial	myocardial	JJ	B-NP	O
infarction	infarction	NN	I-NP	O
by	by	IN	B-PP	O
enzymes	enzyme	NNS	B-NP	B-protein
and	and	CC	O	O
her	her	PRP$	B-NP	O
ECG	ECG	NN	I-NP	B-protein
continued	continue	VBD	B-VP	O
to	to	TO	I-VP	O
show	show	VB	I-VP	O
new	new	JJ	B-NP	O
lateral	lateral	JJ	I-NP	O
T-wave	T-wave	NN	I-NP	O
changes	change	NNS	I-NP	O
.	.	.	O	O

There	There	EX	B-NP	O
was	be	VBD	B-VP	O
no	no	DT	B-NP	O
evolution	evolution	NN	I-NP	O
or	or	CC	I-NP	O
change	change	NN	I-NP	O
in	in	IN	B-PP	O
these	these	DT	B-NP	O
throughout	throughout	IN	B-PP	O
the	the	DT	B-NP	O
course	course	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
admission	admission	NN	I-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
10/22/98	10/22/98	CD	B-NP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
underwent	undergo	VBD	B-VP	O
a	a	DT	B-NP	O
Dobutamine	Dobutamine	NN	I-NP	O
MIBI	MIBI	NNP	I-NP	O
study	study	NN	I-NP	O
after	after	IN	B-PP	O
discussion	discussion	NN	B-NP	O
with	with	IN	B-PP	O
her	her	PRP$	B-NP	O
primary	primary	JJ	I-NP	O
care	care	NN	I-NP	O
physician	physician	NN	I-NP	O
and	and	CC	I-NP	O
cardiologist	cardiologist	NN	I-NP	O
,	,	,	O	O
Dr.	Dr.	NNP	B-NP	O
Ginkel	Ginkel	NNP	I-NP	O
,	,	,	O	O
who	who	WP	B-NP	O
felt	feel	VBD	B-VP	O
that	that	IN	B-SBAR	O
this	this	DT	B-NP	O
would	would	MD	B-VP	O
be	be	VB	I-VP	O
a	a	DT	B-NP	O
helpful	helpful	JJ	I-NP	O
study	study	NN	I-NP	O
,	,	,	O	O
given	give	VBN	B-PP	O
her	her	PRP$	B-NP	O
difficult	difficult	JJ	I-NP	O
history	history	NN	I-NP	O
and	and	CC	O	O
known	know	VBN	B-VP	O
underlying	underlie	VBG	B-VP	O
coronary	coronary	JJ	B-NP	O
artery	artery	NN	I-NP	O
disease	disease	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
results	result	NNS	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
Dobutamine	Dobutamine	NN	I-NP	O
study	study	NN	I-NP	O
were	be	VBD	B-VP	O
that	that	IN	B-SBAR	O
she	she	PRP	B-NP	O
had	have	VBD	B-VP	O
no	no	DT	B-NP	O
ECG	ECG	NN	I-NP	O
changes	change	NNS	I-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
MIBI	MIBI	NNP	I-NP	O
images	image	NNS	I-NP	O
showed	show	VBD	B-VP	O
lateral	lateral	JJ	B-NP	O
and	and	CC	I-NP	O
inferior	inferior	JJ	I-NP	O
infarcts	infarct	NNS	I-NP	O
but	but	CC	O	O
no	no	DT	B-NP	O
active	active	JJ	I-NP	O
ischemia	ischemia	NN	I-NP	O
.	.	.	O	O

Over	Over	IN	B-PP	O
the	the	DT	B-NP	O
course	course	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
first	first	JJ	I-NP	O
couple	couple	NN	I-NP	O
of	of	IN	B-PP	O
days	day	NNS	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
admission	admission	NN	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
blood	blood	NN	I-NP	O
pressure	pressure	NN	I-NP	O
was	be	VBD	B-VP	O
noted	note	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
lower	low	JJR	B-ADJP	O
than	than	IN	B-PP	O
her	her	PRP$	B-NP	O
usual	usual	JJ	I-NP	O
baseline	baseline	NN	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
diuretics	diuretic	NNS	I-NP	O
were	be	VBD	B-VP	O
held	hold	VBN	I-VP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
thought	thought	NN	I-NP	O
that	that	IN	B-NP	O
her	her	PRP$	B-NP	O
elevated	elevated	JJ	I-NP	O
creatinine	creatinine	NN	I-NP	O
,	,	,	O	O
lightheadedness	lightheadedness	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
general	general	JJ	B-NP	O
malaise	malaise	NN	I-NP	O
were	be	VBD	B-VP	O
probably	probably	RB	B-ADVP	O
due	due	JJ	B-ADJP	O
to	to	TO	B-PP	O
dehydration	dehydration	NN	B-NP	O
,	,	,	O	O
given	give	VBN	B-PP	O
that	that	IN	B-SBAR	O
her	her	PRP$	B-NP	O
Bumex	Bumex	NNP	I-NP	O
dose	dose	NN	I-NP	O
had	have	VBD	B-VP	O
recently	recently	RB	I-VP	O
been	be	VBN	I-VP	O
increased	increase	VBN	I-VP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
gently	gently	RB	I-VP	O
hydrated	hydrate	VBN	I-VP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
total	total	NN	I-NP	O
of	of	IN	B-PP	O
about	about	IN	B-NP	O
3	3	CD	I-NP	O
liters	liter	NNS	I-NP	O
and	and	CC	O	O
her	her	PRP$	B-NP	O
blood	blood	NN	I-NP	O
pressure	pressure	NN	I-NP	O
increased	increase	VBD	B-VP	O
somewhat	somewhat	RB	B-ADVP	O
.	.	.	O	O

A	A	DT	B-NP	O
follow-up	follow-up	JJ	I-NP	O
chest	chest	NN	I-NP	O
x-ray	x-ray	NN	I-NP	O
was	be	VBD	B-VP	O
done	do	VBN	I-VP	O
which	which	WDT	B-NP	O
did	do	VBD	B-VP	O
not	not	RB	I-VP	O
show	show	VB	I-VP	O
any	any	DT	B-NP	O
evidence	evidence	NN	I-NP	O
of	of	IN	B-PP	O
congestive	congestive	JJ	B-NP	O
heart	heart	NN	I-NP	O
failure	failure	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
no	no	DT	B-NP	O
other	other	JJ	I-NP	O
active	active	JJ	I-NP	O
cardiac	cardiac	JJ	I-NP	O
issues	issue	NNS	I-NP	O
during	during	IN	B-PP	O
this	this	DT	B-NP	O
admission	admission	NN	I-NP	O
.	.	.	O	O

Renal	Renal	JJ	B-ADJP	O
:	:	:	O	O
At	At	IN	B-PP	O
the	the	DT	B-NP	O
time	time	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
admission	admission	NN	I-NP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
creatinine	creatinine	NN	I-NP	O
was	be	VBD	B-VP	O
2.5	2.5	CD	B-NP	O
.	.	.	O	O

It	It	PRP	B-NP	O
subsequently	subsequently	RB	B-ADVP	O
bumped	bump	VBD	B-VP	O
to	to	TO	B-PP	O
a	a	DT	B-NP	O
maximum	maximum	NN	I-NP	O
of	of	IN	B-PP	O
2.9	2.9	CD	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
setting	setting	NN	I-NP	O
of	of	IN	B-PP	O
her	her	PRP$	B-NP	O
dehydration	dehydration	NN	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
blood	blood	NN	I-NP	O
pressure	pressure	NN	I-NP	O
medications	medication	NNS	I-NP	O
were	be	VBD	B-VP	O
held	hold	VBN	I-VP	O
and	and	CC	O	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
gently	gently	RB	I-VP	O
rehydrated	rehydrate	VBN	I-VP	O
.	.	.	O	O

With	With	IN	B-PP	O
this	this	DT	B-NP	O
treatment	treatment	NN	I-NP	O
,	,	,	O	O
her	her	PRP$	B-NP	O
creatinine	creatinine	NN	I-NP	O
returned	return	VBD	B-VP	O
to	to	TO	B-PP	O
its	its	PRP$	B-NP	O
baseline	baseline	NN	I-NP	O
of	of	IN	B-PP	O
approximately	approximately	RB	B-NP	O
1.5	1.5	CD	I-NP	O
to	to	TO	B-PP	O
1.6	1.6	CD	B-NP	O
.	.	.	O	O

At	At	IN	B-PP	O
the	the	DT	B-NP	O
time	time	NN	I-NP	O
of	of	IN	B-PP	O
admission	admission	NN	B-NP	O
there	there	EX	B-NP	O
was	be	VBD	B-VP	O
some	some	DT	B-NP	O
question	question	NN	I-NP	O
as	as	IN	B-PP	O
to	to	TO	B-PP	O
whether	whether	IN	B-SBAR	O
she	she	PRP	B-NP	O
might	might	MD	B-VP	O
have	have	VB	I-VP	O
a	a	DT	B-NP	O
urinary	urinary	JJ	I-NP	O
tract	tract	NN	I-NP	O
infection	infection	NN	I-NP	O
given	give	VBN	B-VP	O
her	her	PRP$	B-NP	O
urinalysis	urinalysis	NN	I-NP	O
;	;	:	O	O
however	however	RB	B-ADVP	O
,	,	,	O	O
a	a	DT	B-NP	O
urine	urine	NN	I-NP	O
culture	culture	NN	I-NP	O
came	come	VBD	B-VP	O
back	back	RB	B-ADVP	O
negative	negative	JJ	B-ADJP	O
.	.	.	O	O

The	The	DT	B-NP	O
white	white	JJ	I-NP	B-cell_type
blood	blood	NN	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
in	in	IN	B-PP	O
her	her	PRP$	B-NP	O
urine	urine	NN	I-NP	O
on	on	IN	B-PP	O
admission	admission	NN	B-NP	O
were	be	VBD	B-VP	O
not	not	RB	O	O
present	present	JJ	B-ADJP	O
on	on	IN	B-PP	O
a	a	DT	B-NP	O
subsequent	subsequent	JJ	I-NP	O
specimen	specimen	NN	I-NP	O
which	which	WDT	B-NP	O
was	be	VBD	B-VP	O
obtained	obtain	VBN	I-VP	O
by	by	IN	B-PP	O
straight	straight	JJ	B-NP	O
catheterization	catheterization	NN	I-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
thought	thought	NN	I-NP	O
was	be	VBD	B-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
initial	initial	JJ	I-NP	O
pyuria	pyuria	NN	I-NP	O
was	be	VBD	B-VP	O
probably	probably	RB	I-VP	O
related	relate	VBN	I-VP	O
to	to	TO	B-PP	O
vaginal	vaginal	JJ	B-NP	O
candidiasis	candidiasis	NN	I-NP	O
.	.	.	O	O

Pulmonary	Pulmonary	JJ	B-ADJP	O
:	:	:	O	O
Over	Over	IN	B-PP	O
the	the	DT	B-NP	O
course	course	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
first	first	JJ	I-NP	O
three	three	CD	I-NP	O
or	or	CC	I-NP	O
four	four	CD	I-NP	O
days	day	NNS	I-NP	O
of	of	IN	B-PP	O
admission	admission	NN	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
developed	develop	VBD	B-VP	O
a	a	DT	B-NP	O
somewhat	somewhat	RB	I-NP	O
increasing	increase	VBG	I-NP	O
oxygen	oxygen	NN	I-NP	O
requirement	requirement	NN	I-NP	O
for	for	IN	B-PP	O
unclear	unclear	JJ	B-NP	O
reasons	reason	NNS	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
need	need	NN	I-NP	O
for	for	IN	B-PP	O
oxygen	oxygen	NN	B-NP	O
waxed	wax	VBD	B-VP	O
and	and	CC	I-VP	O
waned	wan	VBD	I-VP	O
but	but	CC	O	O
,	,	,	O	O
because	because	IN	B-PP	O
of	of	IN	I-PP	O
her	her	PRP$	B-NP	O
habitus	habitus	NN	I-NP	O
and	and	CC	O	O
her	her	PRP$	B-NP	O
general	general	JJ	I-NP	O
complaints	complaint	NNS	I-NP	O
of	of	IN	B-PP	O
dyspnea	dyspnea	NN	B-NP	O
over	over	IN	B-PP	O
the	the	DT	B-NP	O
last	last	JJ	I-NP	O
several	several	JJ	I-NP	O
months	month	NNS	I-NP	O
,	,	,	O	O
there	there	EX	B-NP	O
was	be	VBD	B-VP	O
some	some	DT	B-NP	O
concern	concern	NN	I-NP	O
that	that	IN	B-SBAR	O
she	she	PRP	B-NP	O
may	may	MD	B-VP	O
be	be	VB	I-VP	O
having	have	VBG	I-VP	O
chronic	chronic	JJ	B-NP	O
pulmonary	pulmonary	JJ	I-NP	O
embolus	embolus	NN	I-NP	O
.	.	.	O	O

For	For	IN	B-PP	O
this	this	DT	B-NP	O
reason	reason	NN	I-NP	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
taken	take	VBN	I-VP	O
to	to	TO	B-PP	O
VQ	VQ	NN	B-NP	O
scan	scan	NN	I-NP	O
on	on	IN	B-PP	O
1/18/98	1/18/98	CD	B-NP	O
.	.	.	O	O

This	This	DT	B-NP	O
study	study	NN	I-NP	O
was	be	VBD	B-VP	O
read	read	VBN	I-VP	O
as	as	IN	B-PP	O
low	low	JJ	B-NP	O
probability	probability	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
transiently	transiently	RB	I-VP	O
anticoagulated	anticoagulate	VBN	I-VP	O
while	while	IN	B-SBAR	O
awaiting	await	VBG	B-VP	O
the	the	DT	B-NP	O
results	result	NNS	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
scan	scan	NN	I-NP	O
but	but	CC	O	O
the	the	DT	B-NP	O
heparin	heparin	NN	I-NP	O
was	be	VBD	B-VP	O
subsequently	subsequently	RB	I-VP	O
discontinued	discontinue	VBN	I-VP	O
.	.	.	O	O

The	The	DT	B-NP	O
reasons	reason	NNS	I-NP	O
for	for	IN	B-PP	O
her	her	PRP$	B-NP	O
increase	increase	NN	I-NP	O
in	in	IN	B-PP	O
oxygen	oxygen	NN	B-NP	O
requirement	requirement	NN	I-NP	O
during	during	IN	B-PP	O
the	the	DT	B-NP	O
course	course	NN	I-NP	O
of	of	IN	B-PP	O
this	this	DT	B-NP	O
admission	admission	NN	I-NP	O
remained	remain	VBD	B-VP	O
somewhat	somewhat	RB	B-ADJP	O
unclear	unclear	JJ	I-ADJP	O
.	.	.	O	O

It	It	PRP	B-NP	O
is	be	VBZ	B-VP	O
possible	possible	JJ	B-ADJP	O
that	that	IN	B-SBAR	O
she	she	PRP	B-NP	O
has	have	VBZ	B-VP	O
sleep	sleep	JJ	B-NP	O
apnea	apnea	NN	I-NP	O
given	give	VBN	B-VP	O
her	her	PRP$	B-NP	O
body	body	NN	I-NP	O
habitus	habitus	NN	I-NP	O
and	and	CC	O	O
this	this	DT	B-NP	O
would	would	MD	B-VP	O
warrant	warrant	VB	I-VP	O
follow-up	follow-up	NN	B-NP	O
as	as	IN	B-PP	O
an	an	DT	B-NP	O
outpatient	outpatient	NN	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
oxygen	oxygen	NN	I-NP	O
saturation	saturation	NN	I-NP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
time	time	NN	I-NP	O
of	of	IN	B-PP	O
discharge	discharge	NN	B-NP	O
is	be	VBZ	B-VP	O
approximately	approximately	RB	B-NP	O
92	92	CD	I-NP	O
%	%	NN	I-NP	O
on	on	IN	B-PP	O
room	room	NN	B-NP	O
air	air	NN	I-NP	O
.	.	.	O	O

Endocrine	Endocrine	JJ	B-ADJP	O
:	:	:	O	O
At	At	IN	B-PP	O
the	the	DT	B-NP	O
time	time	NN	I-NP	O
of	of	IN	B-PP	O
admission	admission	NN	B-NP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
blood	blood	NN	B-NP	O
sugars	sugar	NNS	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
range	range	NN	I-NP	O
of	of	IN	B-PP	O
400	400	CD	B-NP	B-DNA
to	to	TO	B-PP	I-DNA
500	500	CD	B-NP	I-DNA
.	.	.	O	O

Her	Her	PRP$	B-NP	O
insulin	insulin	NN	I-NP	O
doses	dose	NNS	I-NP	O
were	be	VBD	B-VP	O
increased	increase	VBN	I-VP	O
in	in	IN	B-SBAR	O
order	order	NN	O	O
to	to	TO	B-VP	O
obtain	obtain	VB	I-VP	O
better	well	RBR	B-NP	O
glycemic	glycemic	JJ	I-NP	O
control	control	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
reason	reason	NN	I-NP	O
for	for	IN	B-PP	O
her	her	PRP$	B-NP	O
sudden	sudden	JJ	I-NP	O
increase	increase	NN	I-NP	O
in	in	IN	B-PP	O
insulin	insulin	NN	B-NP	O
needs	need	NNS	I-NP	O
remains	remain	VBZ	B-VP	O
elusive	elusive	JJ	B-ADJP	O
.	.	.	O	O

Orthopedics	Orthopedic	NNS	B-NP	O
:	:	:	O	O
At	At	IN	B-PP	O
the	the	DT	B-NP	O
time	time	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
admission	admission	NN	I-NP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
set	set	NN	I-NP	O
of	of	IN	B-PP	O
lumbosacral	lumbosacral	JJ	B-NP	B-cell_type
spine	spine	NN	I-NP	I-cell_type
films	film	NNS	I-NP	I-cell_type
done	do	VBN	B-VP	O
in	in	IN	B-SBAR	O
order	order	NN	O	O
to	to	TO	B-VP	O
rule	rule	VB	I-VP	O
out	out	RP	B-PRT	O
injuries	injury	NNS	B-NP	O
related	relate	VBN	B-VP	O
to	to	TO	B-PP	O
her	her	PRP$	B-NP	O
fall	fall	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
films	film	NNS	I-NP	O
were	be	VBD	B-VP	O
read	read	VBN	I-VP	O
as	as	IN	B-PP	O
showing	show	VBG	B-VP	O
a	a	DT	B-NP	O
potential	potential	JJ	I-NP	O
subtle	subtle	JJ	I-NP	O
fracture	fracture	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
coccyx	coccyx	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
significant	significant	JJ	I-NP	O
amount	amount	NN	I-NP	O
of	of	IN	B-PP	O
pain	pain	NN	B-NP	O
in	in	IN	B-PP	O
this	this	DT	B-NP	O
area	area	NN	I-NP	O
over	over	IN	B-PP	O
the	the	DT	B-NP	O
course	course	NN	I-NP	O
of	of	IN	B-PP	O
admission	admission	NN	B-NP	O
and	and	CC	O	O
it	it	PRP	B-NP	O
was	be	VBD	B-VP	O
thought	think	VBN	I-VP	O
likely	likely	RB	B-ADJP	O
that	that	IN	B-SBAR	O
she	she	PRP	B-NP	O
did	do	VBD	B-VP	O
,	,	,	O	O
indeed	indeed	RB	B-ADVP	O
,	,	,	O	O
have	have	VBP	B-VP	O
a	a	DT	B-NP	O
fracture	fracture	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
working	work	VBG	I-VP	O
with	with	IN	B-PP	O
physical	physical	JJ	B-NP	O
therapy	therapy	NN	I-NP	O
in	in	IN	B-SBAR	O
order	order	NN	O	O
to	to	TO	B-VP	O
increase	increase	VB	I-VP	O
her	her	PRP$	B-NP	O
mobility	mobility	NN	I-NP	O
.	.	.	O	O

Gastrointestinal	Gastrointestinal	JJ	B-ADJP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
been	be	VBN	I-VP	O
complaining	complain	VBG	I-VP	O
over	over	IN	B-PP	O
this	this	DT	B-NP	O
admission	admission	NN	I-NP	O
of	of	IN	B-PP	O
some	some	DT	B-NP	O
burning	burning	NN	I-NP	O
in	in	IN	B-PP	O
her	her	PRP$	B-NP	O
esophagus	esophagus	NN	I-NP	O
,	,	,	O	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
some	some	DT	B-NP	O
epigastric	epigastric	JJ	I-NP	O
tenderness	tenderness	NN	I-NP	O
.	.	.	O	O

It	It	PRP	B-NP	O
seems	seem	VBZ	B-VP	O
from	from	IN	B-PP	O
review	review	NN	B-NP	O
of	of	IN	B-PP	O
her	her	PRP$	B-NP	O
records	record	NNS	I-NP	O
that	that	IN	B-SBAR	O
this	this	DT	B-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
a	a	DT	B-NP	O
chronic	chronic	JJ	I-NP	O
problem	problem	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
started	start	VBN	I-VP	O
on	on	IN	B-PP	O
Cisapride	Cisapride	NN	B-NP	B-DNA
for	for	IN	B-PP	I-DNA
presumptive	presumptive	JJ	B-NP	I-DNA
element	element	NN	I-NP	I-DNA
of	of	IN	B-PP	O
diabetic	diabetic	JJ	B-NP	O
gastroparesis	gastroparesis	NN	I-NP	O
,	,	,	O	O
in	in	IN	B-PP	O
addition	addition	NN	B-NP	O
to	to	TO	B-PP	O
being	be	VBG	B-VP	O
maintained	maintain	VBN	I-VP	O
on	on	IN	B-PP	O
her	her	PRP$	B-NP	B-cell_type
Prilosec	Prilosec	NN	I-NP	I-cell_type
.	.	.	O	O

Of	Of	IN	B-PP	O
note	note	NN	B-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
had	have	VBD	B-VP	O
recently	recently	RB	I-VP	O
undergone	undergo	VBN	I-VP	O
endoscopy	endoscopy	NN	B-NP	O
and	and	CC	O	O
been	be	VBN	B-VP	O
diagnosed	diagnose	VBN	I-VP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
question	question	NN	I-NP	O
of	of	IN	B-PP	O
Helicobacter	Helicobacter	NN	B-NP	O
pylori	pylori	NN	I-NP	O
infection	infection	NN	I-NP	O
which	which	WDT	B-NP	O
has	have	VBZ	B-VP	O
now	now	RB	I-VP	O
been	be	VBN	I-VP	O
treated	treat	VBN	I-VP	O
.	.	.	O	O

However	However	RB	B-ADVP	O
,	,	,	O	O
her	her	PRP$	B-NP	O
symptoms	symptom	NNS	I-NP	O
continue	continue	VBP	B-VP	O
.	.	.	O	O

In	In	IN	B-PP	O
addition	addition	NN	B-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
had	have	VBD	B-VP	O
recently	recently	RB	I-VP	O
had	have	VBD	I-VP	O
a	a	DT	B-NP	O
barium	barium	NN	I-NP	O
study	study	NN	I-NP	O
in	in	IN	B-PP	O
April	April	NNP	B-NP	O
of	of	IN	B-PP	O
1996	1996	CD	B-NP	O
that	that	WDT	B-NP	O
showed	show	VBD	B-VP	O
no	no	DT	B-NP	O
abnormalities	abnormality	NNS	I-NP	O
.	.	.	O	O

It	It	PRP	B-NP	O
was	be	VBD	B-VP	O
decided	decide	VBN	I-VP	O
that	that	IN	B-SBAR	O
this	this	DT	B-NP	O
study	study	NN	I-NP	O
did	do	VBD	B-VP	O
not	not	RB	I-VP	O
warrant	warrant	VB	I-VP	O
repeating	repeat	VBG	I-VP	O
at	at	IN	B-PP	O
this	this	DT	B-NP	O
point	point	NN	I-NP	O
.	.	.	O	O

Neurologic	Neurologic	JJ	B-ADJP	O
:	:	:	O	O
On	On	IN	B-PP	O
several	several	JJ	B-NP	O
occasions	occasion	NNS	I-NP	O
during	during	IN	B-PP	O
this	this	DT	B-NP	O
admission	admission	NN	I-NP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
became	become	VBD	B-VP	O
acutely	acutely	RB	B-ADJP	O
confused	confuse	VBN	I-ADJP	O
.	.	.	O	O

At	At	IN	B-PP	O
these	these	DT	B-NP	O
times	time	NNS	I-NP	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
not	not	RB	I-VP	O
noted	note	VBN	I-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
a	a	DT	B-NP	O
focal	focal	JJ	I-NP	O
neurological	neurological	JJ	I-NP	O
examination	examination	NN	I-NP	O
.	.	.	O	O

These	These	DT	B-NP	O
instances	instance	NNS	I-NP	O
appeared	appear	VBD	B-VP	O
questionably	questionably	RB	B-ADJP	O
related	relate	VBN	I-ADJP	O
to	to	TO	B-PP	O
dosing	dosing	NN	B-NP	O
of	of	IN	B-PP	O
her	her	PRP$	B-NP	O
Compazine	Compazine	NN	I-NP	O
and	and	CC	O	O
also	also	RB	B-ADVP	O
all	all	DT	B-NP	O
seemed	seem	VBD	B-VP	O
to	to	TO	I-VP	O
occur	occur	VB	I-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
evening	evening	NN	I-NP	O
.	.	.	O	O

It	It	PRP	B-NP	O
was	be	VBD	B-VP	O
thought	think	VBN	I-VP	O
that	that	IN	B-SBAR	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
probably	probably	RB	I-VP	O
sundowning	sundowne	VBG	I-VP	O
and	and	CC	O	O
,	,	,	O	O
during	during	IN	B-PP	O
her	her	PRP$	B-NP	O
clearer	clear	JJR	I-NP	O
moments	moment	NNS	I-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
reported	report	VBD	B-VP	O
having	have	VBG	I-VP	O
similar	similar	JJ	B-NP	O
problems	problem	NNS	I-NP	O
at	at	IN	B-PP	O
home	home	NN	B-NP	O
.	.	.	O	O

Infectious	Infectious	JJ	B-NP	O
disease	disease	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
began	begin	VBD	B-VP	O
having	have	VBG	I-VP	O
some	some	DT	B-NP	O
low	low	JJ	I-NP	O
grade	grade	NN	I-NP	O
fevers	fever	NNS	I-NP	O
on	on	IN	B-PP	O
approximately	approximately	RB	B-NP	O
hospital	hospital	NN	I-NP	O
day	day	NN	I-NP	O
#	#	#	B-NP	O
4	4	CD	I-NP	O
.	.	.	O	O

Blood	Blood	NN	B-NP	O
and	and	CC	I-NP	O
urine	urine	NN	I-NP	O
cultures	culture	NNS	I-NP	O
at	at	IN	B-PP	O
that	that	DT	B-NP	O
time	time	NN	I-NP	O
were	be	VBD	B-VP	O
negative	negative	JJ	B-ADJP	O
.	.	.	O	O

Because	Because	IN	B-PP	O
of	of	IN	I-PP	O
the	the	DT	B-NP	O
low	low	JJ	I-NP	O
grade	grade	NN	I-NP	O
fevers	fever	NNS	I-NP	O
and	and	CC	O	O
her	her	PRP$	B-NP	O
decreased	decrease	VBN	I-NP	O
oxygen	oxygen	NN	I-NP	O
saturation	saturation	NN	I-NP	O
intermittently	intermittently	RB	B-ADVP	O
,	,	,	O	O
chest	chest	NN	B-NP	O
x-ray	x-ray	NN	I-NP	O
and	and	CC	O	O
VQ	VQ	NN	B-NP	O
scan	scan	NN	I-NP	O
were	be	VBD	B-VP	O
done	do	VBN	I-VP	O
.	.	.	O	O

The	The	DT	B-NP	O
VQ	VQ	NN	I-NP	O
scan	scan	NN	I-NP	O
was	be	VBD	B-VP	O
read	read	VBN	I-VP	O
as	as	IN	B-PP	O
low	low	JJ	B-NP	O
probability	probability	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
chest	chest	NN	I-NP	O
x-ray	x-ray	NN	I-NP	O
was	be	VBD	B-VP	O
read	read	VBN	I-VP	O
as	as	IN	B-PP	O
having	have	VBG	B-VP	O
some	some	DT	B-NP	O
atelectasis	atelectasis	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
left	left	JJ	I-NP	O
lower	low	JJR	I-NP	O
lobe	lobe	NN	I-NP	O
.	.	.	O	O

There	There	EX	B-NP	O
was	be	VBD	B-VP	O
a	a	DT	B-NP	O
question	question	NN	I-NP	O
of	of	IN	B-PP	O
whether	whether	IN	B-SBAR	O
this	this	DT	B-NP	O
was	be	VBD	B-VP	O
atelectasis	atelectasis	NN	B-NP	O
versus	versus	IN	B-PP	O
an	an	DT	B-NP	O
infiltrate	infiltrate	NN	I-NP	O
.	.	.	O	O

However	However	RB	B-ADVP	O
,	,	,	O	O
since	since	IN	B-SBAR	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
remained	remain	VBD	B-VP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
normal	normal	JJ	I-NP	O
WBC	WBC	NN	I-NP	O
and	and	CC	O	O
no	no	DT	B-NP	O
purulent	purulent	JJ	I-NP	O
sputum	sputum	NN	I-NP	O
,	,	,	O	O
it	it	PRP	B-NP	O
was	be	VBD	B-VP	O
thought	think	VBN	I-VP	O
unlikely	unlikely	JJ	B-ADJP	O
that	that	IN	B-SBAR	O
she	she	PRP	B-NP	O
had	have	VBD	B-VP	O
pneumonia	pneumonia	NN	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
also	also	RB	B-ADVP	O
reported	report	VBD	B-VP	O
having	have	VBG	I-VP	O
some	some	DT	B-NP	O
congestion	congestion	NN	I-NP	O
and	and	CC	O	O
it	it	PRP	B-NP	O
was	be	VBD	B-VP	O
thought	think	VBN	I-VP	O
that	that	IN	B-SBAR	O
she	she	PRP	B-NP	O
might	might	MD	B-VP	O
be	be	VB	I-VP	O
having	have	VBG	I-VP	O
low	low	JJ	B-NP	O
grade	grade	NN	I-NP	O
fevers	fever	NNS	I-NP	O
from	from	IN	B-PP	O
a	a	DT	B-NP	O
upper	upper	JJ	I-NP	O
respiratory	respiratory	JJ	I-NP	O
infection	infection	NN	I-NP	O
.	.	.	O	O

DISPOSITION	DISPOSITION	NN	B-NP	O
:	:	:	O	O
DISCHARGE	DISCHARGE	NN	B-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
:	:	:	O	O
Albuterol	Albuterol	NNP	B-NP	O
inhaler	inhal	JJR	B-NP	O
2	2	CD	I-NP	O
puffs	puff	NNS	I-NP	O
q.i.d.	q.i.d.	RB	B-ADVP	O
,	,	,	O	O
Enteric	Enteric	JJ	B-NP	O
coated	coated	JJ	I-NP	O
aspirin	aspirin	NN	I-NP	O
325	325	CD	I-NP	O
mg	mg	NN	I-NP	O
q.d.	q.d.	NN	I-NP	O
,	,	,	O	O
Atenolol	Atenolol	NNP	B-NP	O
25	25	CD	I-NP	O
mg	mg	NN	I-NP	O
q.d.	q.d.	NN	I-NP	O
,	,	,	O	O
Colace	Colace	NNP	B-NP	O
100	100	CD	I-NP	O
mg	mg	NN	I-NP	O
b.i.d.	b.i.d.	RB	B-ADVP	O
,	,	,	O	O
NPH	NPH	NN	B-NP	O
insulin	insulin	NN	I-NP	O
95	95	CD	B-NP	O
q.a.m.	q.a.m.	NN	I-NP	O
and	and	CC	O	O
45	45	CD	B-NP	O
q.p.m.	q.p.m.	NN	I-NP	O
,	,	,	O	O
sliding	slide	VBG	B-VP	O
scale	scale	NN	B-NP	O
insulin	insulin	NN	I-NP	O
q.ac	q.ac	NN	I-NP	O
.	.	.	O	O

and	and	CC	O	O
qhs	qh	NNS	B-NP	O
,	,	,	O	O
regular	regular	JJ	B-NP	O
insulin	insulin	NN	I-NP	O
30	30	CD	I-NP	O
q.a.m.	q.a.m.	NN	I-NP	O
and	and	CC	O	O
20	20	CD	B-NP	O
q.p.m.	q.p.m.	NN	I-NP	O
,	,	,	O	O
Atrovent	Atrovent	NNP	B-NP	O
inhaler	inhal	JJR	I-NP	O
2	2	CD	I-NP	O
puffs	puff	NNS	I-NP	O
q.i.d.	q.i.d.	NN	I-NP	O
,	,	,	O	O
Isordil	Isordil	NN	B-NP	O
10	10	CD	I-NP	O
mg	mg	NN	I-NP	O
t.i.d.	t.i.d.	NN	I-NP	O
-	-	HYPH	O	O
hold	hold	NN	B-NP	O
for	for	IN	B-PP	O
systolic	systolic	JJ	B-NP	O
blood	blood	NN	I-NP	O
pressure	pressure	NN	I-NP	O
less	less	JJR	B-ADJP	O
than	than	IN	B-PP	O
100	100	CD	B-NP	O
,	,	,	O	O
Lisinopril	Lisinopril	NNP	B-NP	O
30	30	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
q.d.	q.d.	AFX	B-NP	O
-	-	HYPH	I-NP	O
hold	hold	NN	B-NP	O
for	for	IN	B-PP	O
systolic	systolic	JJ	B-NP	O
blood	blood	NN	I-NP	O
pressure	pressure	NN	I-NP	O
less	less	JJR	B-ADJP	O
than	than	IN	B-PP	O
100	100	CD	B-NP	O
,	,	,	O	O
Prilosec	Prilosec	NNP	B-NP	O
20	20	CD	I-NP	O
mg	mg	NN	I-NP	O
q.d.	q.d.	NN	I-NP	O
,	,	,	O	O
Cisapride	Cisapride	NN	B-NP	O
10	10	CD	I-NP	O
mg	mg	NN	I-NP	O
q.i.d.	q.i.d.	NN	I-NP	O
,	,	,	O	O
Pravastatin	Pravastatin	NN	B-NP	O
20	20	CD	I-NP	O
mg	mg	NN	I-NP	O
qhs	qh	NNS	I-NP	O
,	,	,	O	O
Allegra	Allegra	NNP	B-NP	O
60	60	CD	I-NP	O
mg	mg	NN	I-NP	O
b.i.d.	b.i.d.	RB	B-ADVP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
discharged	discharge	VBN	I-VP	O
to	to	TO	B-PP	O
rehabilitation	rehabilitation	NN	B-NP	O
because	because	IN	B-PP	O
of	of	IN	I-PP	O
her	her	PRP$	B-NP	O
difficulty	difficulty	NN	I-NP	O
with	with	IN	B-PP	O
walking	walk	VBG	B-NP	O
.	.	.	O	O

FOLLOWUP	FOLLOWUP	NN	B-NP	O
:	:	:	O	O
She	She	PRP	B-NP	O
will	will	MD	B-VP	O
follow-up	follow-up	VB	I-VP	O
in	in	IN	B-PP	O
clinic	clinic	NN	B-NP	O
with	with	IN	B-PP	O
her	her	PRP$	B-NP	O
cardiologist	cardiologist	NN	I-NP	O
,	,	,	O	O
Dr.	Dr.	NNP	B-NP	O
Berken	Berken	NNP	I-NP	O
,	,	,	O	O
and	and	CC	O	O
with	with	IN	B-PP	O
her	her	PRP$	B-NP	O
primary	primary	JJ	I-NP	O
care	care	NN	I-NP	O
physician	physician	NN	I-NP	O
,	,	,	O	O
Dr.	Dr.	NNP	B-NP	O
Ismael	Ismael	NNP	I-NP	O
Tabar	Tabar	NNP	I-NP	O
.	.	.	O	O

Dictated	Dictate	VBN	B-VP	O
By	By	IN	B-PP	O
:	:	:	O	O
LOUIS	LOUIS	NNP	B-NP	O
SISTA	SISTA	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
BT34	BT34	NNP	I-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
HUNTER	HUNTER	NN	B-NP	B-protein
COINS	COINS	NN	I-NP	I-protein
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
DO93	DO93	NNP	I-NP	O
VU911/7730	VU911/7730	NNP	I-NP	O
Batch	Batch	NNP	I-NP	O
:	:	:	O	O
1488	1488	CD	B-NP	O
Index	Index	NNP	I-NP	O
No	No	NNP	I-NP	O
.	.	.	O	O

TACOSA46OV	TACOSA46OV	NN	B-NP	O
D	D	NN	I-NP	O
:	:	:	O	O
8/10/98	8/10/98	CD	B-NP	O
T	T	NN	I-NP	O
:	:	:	O	O
8/10/98	8/10/98	CD	B-NP	O

